Selective modulation of muscarinic receptor subtypes: Therapeutic potential

Emerging Drugs

Volumn 3, Issue , 1998, Pages 67-80

  Eglen, R M ^a   Hegde, S S ^a  

^a ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DICHLORO 6,7,8,9,10,12 HEXAHYDROAZEPINO[2,1 B]QUINAZOLINE; 2,8 DIMETHYL 1,3 DIOXA 8 AZASPIRO[4.5]DECANE; 2,8 DIMETHYL 3 METHYLENE 1 OXA 8 AZASPIRO[4.5]DECANE; 3 (2 DIETHYLAMINO 2 METHYLPROPYLAMINO) 6 PHENYL 5 PROPYLPYRIDAZINE; 3,6A,11,14 TETRAHYDRO 9 METHOXY 2 METHYL 12H ISOQUINO[1,2 B]PYRROLO[3,2 F][1,3]BENZOXAZINE 1 CARBOXYLIC ACID ETHYL ESTER; CEVIMELINE; DIPHENYLPYRALINE; HIMBACINE; ITAMELINE; LY 287041; METHOCTRAMINE; MILAMELINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NERISPIRDINE; PIRENZEPINE; RECEPTOR SUBTYPE; SABCOMELINE; TACRINE; TALSACLIDINE; TRIPITRAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; XANOMELINE;

ALZHEIMER DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; HUMAN; IRRITABLE COLON; REVIEW; URINE INCONTINENCE;

EID: 0031978476     PISSN: 13619195     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728214.3.1.67     Document Type: Review

References (24)